GlassScriptPhysician profile
Aneta Gil
NPI 1891431318
$1,844.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,274 · 2024: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.59 |
| Education | $238.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $370.20 | 2023-2024 | Ilumya, Winlevi, Absorica Ld |
| Regeneron Healthcare Solutions, INC. | $269.06 | 2023-2024 | Dupixent, Libtayo |
| Abbvie INC. | $206.18 | 2023-2024 | |
| Lilly USA, LLC | $186.42 | 2023 | Taltz, Olumiant |
| Verrica Pharmaceuticals INC. | $121.83 | 2024 | Ycanth |
| E.R. Squibb & Sons, L.L.C. | $116.86 | 2023-2024 | Sotyktu |
| Janssen Biotech, INC. | $85.47 | 2023 | Simponi, Stelara, Simponi Aria |
| Galderma Laboratories, L.P. | $80.39 | 2023 | Epsolay, Aklief, Oracea |
| Genzyme Corporation | $74.84 | 2023-2024 | |
| Dermavant Sciences, INC. | $63.87 | 2023-2024 | Vtama |
| Leo Pharma INC. | $45.36 | 2023-2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $44.13 | 2024 | |
| Incyte Corporation | $40.91 | 2023-2024 | Opzelura |
| Amgen INC. | $38.23 | 2023-2024 | Otezla |
| Ucb, INC. | $34.66 | 2023-2024 | Cimzia, Bimzelx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $27.92 | 2023 | Ayvakit |
| Arcutis Biotherapeutics, INC. | $20.40 | 2023 | |
| Biofrontera INC. | $17.79 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneta Gil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.